We agree with Paranthaman et al. that early surveillance data are needed to rapidly inform clinical care guidelines in a pandemic. Therefore, efforts are ongoing to increase the resilience of health surveillance data gathering systems in the United Kingdom and to develop clinical systems for specifi c use during a pandemic. At the onset of a pandemic, it is intended that data will be gathered on the fi rst few hundred patients by using a modifi cation of the Web-based avian infl uenza management system of the Health Protection Agency. These data will provide important virologic and epidemiologic information to characterize the pandemic virus and inform modeling assumptions to validate "now casting" or real-time mathematical models (6) being developed in the United Kingdom and Europe to estimate the likely spread and impact of the pandemic. Furthermore, pilot projects are in preparation to develop clinical data collection systems in secondary care to assess treatments and outcomes during a pandemic.
In conclusion, contingency decisions outside normal patient pathways will be needed; the UK guidance, based on current knowledge and understanding, will help clinicians make diffi cult decisions on patient prioritization, plan surge capacity, build resilience into existing surveillance systems, and develop new systems that seek to inform the best use of resources to deliver optimal clinical care during an infl uenza pandemic. These decisions will be revised and modifi ed to refl ect new developments in the science. In Response: We are grateful to Phin and Davies for providing an update on the pandemic fl u planning situation in the United Kingdom (1) after publication of our letter (2) . We agree with their emphasis that pandemic planning in the United Kindgom is in many regards well developed in comparison with other countries. Many of the updates that they describe provide useful contributions but the fi nal version of UK ethical guidance is more a general statement of principles than a practical guide. Unfortunately, it has pulled back from some of the more defi nite statements in the earlier consultation documents available at the time of our letter.
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An important need for practical guidance for frontline and managerial staff on the ethical aspects of pandemic response remains as a gap in the United Kingdom and elsewhere. For critical care, a useful recent contribution is the report produced by the Task Force on Mass Critical Care, especially the framework for allocation of scarce resources in mass critical care (3). The shift away from pandemic infl uenzaspecifi c criteria to a more generic framework for resource allocation that can compare patients with pandemic infl uenza and those with other usual noninfl uenza conditions is welcome.
Similar practical approaches outside the critical care area are important priorities for work in pandemic preparedness. In addition, systems must be in place for rapid modifi cation and communication of the criteria for referral and admission, taking into account the severity of the pandemic and availability of healthcare resources. Healthcare services must not only be transparent and fair in this process, they must also be seen by the public as being so. Engagement with the public on values and principles underlying resource allocation would be of paramount importance during a pandemic.
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